{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:36:42Z","timestamp":1780472202042,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>We examined management strategies, overall survival (OS), and progression-free survival (PFS) among patients with PMNSGCTs undergoing resection and multidisciplinary management at a high-volume institution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary of Background Data:<\/jats:title>\n            <jats:p>Outcomes after resection of PMNSGCTs are not well-characterized, with limited data on factors associated with survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We reviewed patients with PMNSGCT who underwent resection between 1980 and 2019. Median follow-up was 3.4 years. Preoperative therapy (including use of bleomycin), surgical management, recurrence, and survival were examined. Factors associated with survival were analyzed using Cox regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 113 patients were included [median age, 28 years (range, 16\u201365)]. Preoperative serum tumor markers (STMs) normalized\/decreased in 74% of patients. Pathology included necrosis only (25%), teratoma +\/\u2212 necrosis (20%), viable nonteratomatous germ cell tumor +\/\u2212 teratoma (41%), and secondary somatic-type malignancy +\/\u2212 teratoma (20%). Bleomycin chemotherapy was not associated with pulmonary complications or 90-day mortality. Patients receiving second-line chemotherapy followed by resection had significantly worse OS and PFS than patients receiving first-line chemotherapy followed by resection. On multivariable analysis, R1\/R2 resection (HR, 3.92; P &lt; 0.001) and increasing postoperative STMs (HR, 4.98; P &lt; 0.001) were associated with shorter PFS; necrosis on pathology (HR, 0.42, P = 0.043) was associated with longer PFS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In patients with PMNSGCT undergoing resection, completeness of resection, postoperative pathology, and postoperative STMs were associated with PFS. Induction bleomycin was not associated with pulmonary complications or mortality in patients undergoing resection. Patients undergoing second-line chemotherapy followed by resection have a poor prognosis, with long-term survival of 22%.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sla.0000000000003754","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T18:53:34Z","timestamp":1579892014000},"page":"e1099-e1107","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors"],"prefix":"10.1097","volume":"274","author":[{"given":"Raul","family":"Caso","sequence":"first","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Jones","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjit S.","family":"Bains","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meier","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay See","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Funt","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Bosl","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deaglan","family":"McHugh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Molena","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Amar","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie W.","family":"Rusch","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.299.6.672","article-title":"Medical treatment of advanced testicular cancer","volume":"299","author":"Feldman","year":"2008","journal-title":"JAMA"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/cncr.28025","article-title":"Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older","volume":"119","author":"Feldman","year":"2013","journal-title":"Cancer"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thorsurg.2008.09.002","article-title":"Multimodality treatment of germ cell tumors of the mediastinum","volume":"19","author":"Kesler","year":"2009","journal-title":"Thorac Surg Clin"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1200\/JCO.2016.68.7798","article-title":"Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors","volume":"34","author":"Bagrodia","year":"2016","journal-title":"J Clin Oncol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM199005173222004","article-title":"Hematologic neoplasia associated with primary mediastinal germ-cell tumors","volume":"322","author":"Nichols","year":"1990","journal-title":"N Engl J Med"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1200\/JCO.1987.5.8.1290","article-title":"Klinefelter's syndrome associated with mediastinal germ cell neoplasms","volume":"5","author":"Nichols","year":"1987","journal-title":"J Clin Oncol"},{"key":"R8-20250503","first-page":"653","article-title":"The management of advanced germ cell tumors in 2016: the Memorial Sloan Kettering approach","volume":"30","author":"Funt","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2005.05.4528","article-title":"Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors","volume":"25","author":"Motzer","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1200\/JCO.2016.69.8910","article-title":"Perioperative morbidity and mortality associated with bleomycin in primary mediastinal nonseminomatous germ cell tumor","volume":"34","author":"Ranganath","year":"2016","journal-title":"J Clin Oncol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/JTO.0b013e31821d513e","article-title":"Resection of primary mediastinal non-seminomatous germ cell tumors a 28-year experience at Memorial Sloan-Kettering Cancer Center","volume":"6","author":"Sarkaria","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00432-011-1028-7","article-title":"Treatment strategies and prognostic factors of patients with primary germ cell tumors in the mediastinum","volume":"137","author":"Liu","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<681::AID-CNCR6>3.0.CO;2-Q","article-title":"Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging","volume":"80","author":"Moran","year":"1997","journal-title":"Cancer"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1200\/JCO.2009.25.1561","article-title":"TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis","volume":"28","author":"Feldman","year":"2010","journal-title":"J Clin Oncol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0090-4295(98)00576-7","article-title":"Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors","volume":"53","author":"Albers","year":"1999","journal-title":"Urology"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.athoracsur.2007.09.020","article-title":"A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors","volume":"85","author":"Kesler","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1200\/JCO.2001.19.3.682","article-title":"Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum","volume":"19","author":"Vuky","year":"2001","journal-title":"J Clin Oncol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1998.16.2.725","article-title":"Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy","volume":"16","author":"Fizazi","year":"1998","journal-title":"J Clin Oncol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/1097-0142(19940401)73:7<1971::AID-CNCR2820730731>3.0.CO;2-A","article-title":"Extragonadal germ cell tumors. A 14-year Toronto experience","volume":"73","author":"Goss","year":"1994","journal-title":"Cancer"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5223(99)70015-2","article-title":"Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery","volume":"118","author":"Kesler","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2004.07.102","article-title":"Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer","volume":"22","author":"Schneider","year":"2004","journal-title":"J Clin Oncol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/mdg020","article-title":"Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours","volume":"14","author":"O'Sullivan","year":"2003","journal-title":"Ann Oncol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/bmj.1.6128.1664","article-title":"Factors influencing postoperative morbidity and mortality in patients treated with bleomycin","volume":"1","author":"Goldiner","year":"1978","journal-title":"Br Med J"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000003754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:01:43Z","timestamp":1746252103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000003754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000003754","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]}}}